Besides, Chen and his colleagues have proved that antibodies against UBQLN1 (anti-UBQLN1) can be used for screening lung adenocarcinoma (ADC) patients from healthy individuals [16]. This evidence concerns the gene UBQLN1 and lung adenocarcinoma.